VFM
GILD icon

Vision Financial Markets’s Gilead Sciences GILD Stock Holding History

Vision Financial Markets’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.3K Hold
90
– – 0.01% 239
2026
Q1 		$12.5K Sell
90
-200
-69% -$28K 0.01% 214
2025
Q4 		$35.6K Buy
290
+160
+123% +$19.4K 0.04% 137
2025
Q3 		$14.4K Hold
130
– – 0.01% 221
2025
Q2 		$14.4K Buy
+130
New +$13.8K 0.01% 205

Other funds holding GILD

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Vision Financial Markets's GILD Position: Q2 2026 in Review

Vision Financial Markets held its Gilead Sciences (GILD) position steady in Q2 2026 at 90 shares worth $11.3K. The position accounts for 0.01% of the portfolio, ranked #239.

Vision Financial Markets first reported a position in GILD in Q2 2025 and has held it in 5 quarters since. The position peaked at $35.6K in Q4 2025. 1,154 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Vision Financial Markets held 90 shares of Gilead Sciences worth $11.3K as of Q2 2026.
  • Vision Financial Markets left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.01% of Vision Financial Markets's portfolio in Q2 2026, its #239 holding.
  • Vision Financial Markets first reported a position in Gilead Sciences in Q2 2025 and has held it in 5 quarters since.
  • Vision Financial Markets's Gilead Sciences position peaked at $35.6K in Q4 2025.
  • 1,154 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Vision Financial Markets's 13F filing for Q2 2026, filed 24 Jul 2026.